ID29966A - Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi - Google Patents

Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi

Info

Publication number
ID29966A
ID29966A IDW00200101555A ID20011555A ID29966A ID 29966 A ID29966 A ID 29966A ID W00200101555 A IDW00200101555 A ID W00200101555A ID 20011555 A ID20011555 A ID 20011555A ID 29966 A ID29966 A ID 29966A
Authority
ID
Indonesia
Prior art keywords
sulfonyloksazolamina
therapy
active compounds
compounds
active
Prior art date
Application number
IDW00200101555A
Other languages
English (en)
Indonesian (id)
Inventor
H Greiner
G Bartoszyk
H Bottcher
G Barnickel
B Cezanne
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID29966A publication Critical patent/ID29966A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW00200101555A 1998-12-18 1999-12-01 Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi ID29966A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19858593A DE19858593A1 (de) 1998-12-18 1998-12-18 Sulfonyloxazolamine als therapeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
ID29966A true ID29966A (id) 2001-10-25

Family

ID=7891645

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101555A ID29966A (id) 1998-12-18 1999-12-01 Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi

Country Status (19)

Country Link
US (1) US6441013B1 (zh)
EP (1) EP1140875A1 (zh)
JP (1) JP2002533332A (zh)
CN (1) CN1146549C (zh)
AR (1) AR021896A1 (zh)
AU (1) AU763070B2 (zh)
BR (1) BR9916310A (zh)
CA (1) CA2356134A1 (zh)
CZ (1) CZ20012144A3 (zh)
DE (1) DE19858593A1 (zh)
HK (1) HK1043125A1 (zh)
HU (1) HUP0104834A3 (zh)
ID (1) ID29966A (zh)
NO (1) NO20012965L (zh)
PL (1) PL349393A1 (zh)
RU (1) RU2232757C2 (zh)
SK (1) SK8132001A3 (zh)
WO (1) WO2000037452A1 (zh)
ZA (1) ZA200105881B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956791A1 (de) 1999-11-25 2001-05-31 Merck Patent Gmbh Neue Sulfonyloxazolamine
DE10129940A1 (de) * 2001-06-13 2002-12-19 Merck Patent Gmbh Sulfonyloxazolamine als therapeutische Wirkstoffe
US6875771B2 (en) 2002-07-26 2005-04-05 Bristol-Myers Squibb Company Pyridopyrimidine derivatives as 5-HT6 antagonists
FR2854632B1 (fr) * 2003-05-07 2005-06-17 Centre Nat Rech Scient Synthese de composes heterocycliques substitues
SI1831159T1 (sl) * 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
NZ565470A (en) * 2005-07-29 2010-11-26 4Sc Ag Novel heterocyclic NF-kB inhibitors
US8394788B2 (en) * 2006-11-16 2013-03-12 The Regents Of The University Of California Phenylsulfoxyoxazole compound inhibitors of urea transporters
JP5248528B2 (ja) * 2007-02-02 2013-07-31 エフ．ホフマン−ラ ロシュ アーゲー Ｃｎｓ疾患用のｔａａｒ１リガンドとしての新規２−アミノオキサゾリン
CA2676944C (en) * 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
RU2443697C1 (ru) 2010-12-21 2012-02-27 Александр Васильевич Иващенко Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
WO2018012769A1 (ko) * 2016-07-12 2018-01-18 연세대학교 산학협력단 자가포식 향상물질 및 그 용도
KR102533605B1 (ko) * 2018-01-10 2023-05-17 주식회사 라이조테크 신규한 페닐설포닐 옥사졸 유도체 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029747A1 (en) * 1996-02-20 1997-08-21 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides

Also Published As

Publication number Publication date
EP1140875A1 (de) 2001-10-10
US6441013B1 (en) 2002-08-27
NO20012965D0 (no) 2001-06-15
BR9916310A (pt) 2001-11-06
CZ20012144A3 (cs) 2002-01-16
HK1043125A1 (zh) 2002-09-06
NO20012965L (no) 2001-06-15
CN1146549C (zh) 2004-04-21
CN1331684A (zh) 2002-01-16
AR021896A1 (es) 2002-08-07
JP2002533332A (ja) 2002-10-08
SK8132001A3 (en) 2002-02-05
HUP0104834A3 (en) 2005-06-28
AU1861200A (en) 2000-07-12
ZA200105881B (en) 2002-10-17
HUP0104834A2 (hu) 2002-07-29
RU2232757C2 (ru) 2004-07-20
DE19858593A1 (de) 2000-06-21
AU763070B2 (en) 2003-07-10
PL349393A1 (en) 2002-07-15
WO2000037452A1 (de) 2000-06-29
CA2356134A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
ID22878A (id) Komposisi aktif secara terapi
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
IS2325B (is) Örgerðar samsetningar epleróns
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
EE200200172A (et) Ühendid isheemia ravimiseks
ID27841A (id) Turunan-turunan biaril terapeutik
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
ID29021A (id) Komposisi galantamina pelepasan terkontrol
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
PT1220856E (pt) Compostos farmaceuticamente activos
ID25824A (id) Formulasi terapeutik untuk memberikan tolterodin dengan pelepasan yang terkendali
NO20022692D0 (no) Terapeutiske midler
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
AR028060A1 (es) Combinaciones de compuestos activos fungicidas
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
ID24677A (id) Kombinasi senyawa aktif fungisidal
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO963871D0 (no) Kombinasjoner av aktive insektisidforbindelser
DE59911707D1 (de) Fungizide wirkstoffkombinationen
BR9609288A (pt) Combinações de compostos ativos fungicidas
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
PT1175417E (pt) Compostos substituidos de benzolactamas
ID24922A (id) Terapi kombinasi untuk pengobatan aids